ASG Superconductors with Helmholtz-Zentrum Dresden-Rossendorf (HZDR) will build the world’s first prototype that tracks moving tumors with magnetic resonance imaging (MRI) in real time during proton therapy, combining a rotating open MRI device for the LINAC-MR system Alberta Health Services, with an actively scanned clinical-akin proton beam at OncoRay, the Dresden-based National Center for Radiation Research in Oncology. The rotating MRI device is produced by ASG Superconductors, using the MROpen Evo technology-based helium-free superconducting MgB2 magnet. Real-time MRI would make it possible to synchronize the proton beam to tumor motion during radiation dose delivery. So far, this has been impossible and therefore was a limiting factor for treating moving tumors with this promising cancer therapy.
NEWS
MROPEN EVO at RSNA24: MRI scan time reduced up to 50% at equal quality image.
Genoa, December, 2nd 2024 - Unlocking the future of [...]
MROPENEVO @ RSNA 2024
MROpenEVO on display @ RSNA24 Truly open design - [...]
MROPENEVO @ SIRM 2024
The open MRI technology @SIRM 24. Take a look [...]
Talking about innovation and superconductors technology @ Italian Embassy in Berlin.
Exciting day of Italian research at the Italian Embassy [...]
Our superconducting technology @ International Society for Magnetic Resonance in Medicine ISMRM 24.
Ultra High Field Magnets, Superconductivity, protontherapy and open mri [...]
MRI guided proton therapy session today @ 10th MR in RT Symposium in Rome.
Presentations were held today by Aswin Hoffmann "MRI guided [...]
DISCOVER MORE
